NBTB:NASDAQNBT Bancorp Inc. Analysis
Data as of 2026-05-19 - not real-time
$44.81
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
NBT Bancorp is trading at $44.81, comfortably above its 20‑day SMA (44.52) and 50‑day SMA (43.65) while still below the 200‑day SMA (42.92), indicating a short‑term bullish bias within a longer‑term uptrend. The stock sits near the upper end of its $41.58 support and $45.90 resistance band, with a rising volume trend that supports the bullish momentum, though the MACD histogram is slightly negative, flagging a modest bearish pressure. Fundamentally, the company posted a 21.6% year‑over‑year revenue increase and delivered a non‑GAAP EPS of $0.97, meeting consensus expectations despite a slight revenue miss. Its PE ratio of 12.66 is well below the industry average of 16.48, and the dividend yield of 3.24% with a 41% payout ratio suggests a sustainable income stream. Valuation models imply a fair value of $111.21, translating to roughly a 9% upside from the current price, while the low beta (~0.84) and moderate 30‑day volatility (23.7%) point to a relatively defensive risk profile. The combination of strong earnings growth, attractive dividend, and significant valuation discount makes NBTB a compelling candidate for investors seeking both income and upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings miss but EPS in line with expectations
- Price approaching resistance with slight MACD bearish divergence
- Attractive dividend yield supporting short‑term demand
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap versus DCF fair value
- Robust revenue growth and solid profitability metrics
- Sustainable dividend payout reinforcing total return
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑run upside potential in regional banking markets
- Consistent dividend and low leverage enhancing stability
- Low beta and moderate volatility indicating defensive characteristics
Key Metrics & Analysis
Financial Health
Revenue Growth21.60%
Profit Margin26.36%
P/E Ratio12.7
ROE10.55%
ROA1.22%
P/B Ratio1.2
Op. Cash Flow$246.3M
Industry P/E16.5
Technical Analysis
TrendBullish
RSI53.0
Support$41.58
Resistance$45.90
MA 20$44.52
MA 50$43.65
MA 200$42.92
MACDBearish
VolumeIncreasing
Fear & Greed Index89.18
Valuation
Fair Value$111.21
Target Price$48.92
Upside/Downside9.16%
GradeUndervalued
TypeGrowth
Dividend Yield3.24%
Risk Assessment
Beta0.84
Volatility23.66%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.